| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | 0.055 | 0.09 |
| mRNA | BMS-754807 | GDSC1000 | pan-cancer | AAC | -0.056 | 0.09 |
| mRNA | YL54 | CTRPv2 | pan-cancer | AAC | -0.066 | 0.09 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | 0.059 | 0.09 |
| mRNA | QL-VIII-58 | GDSC1000 | pan-cancer | AAC | 0.076 | 0.09 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | 0.08 | 0.1 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.049 | 0.1 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | 0.052 | 0.1 |
| mRNA | MK-2206 | GDSC1000 | pan-cancer | AAC | 0.059 | 0.1 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.077 | 0.1 |